Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas.
about
EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancerPrognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysisIntegrating Epigenomics into the Understanding of Biomedical InsightBiomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer.Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutationScreening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity.Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.Comment on prognostic value of epidermal growth factor receptor mutation subtypes in surgically resected non-small cell lung cancer.Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma.Prognostic value of and in resected non-small cell lung cancer: a systematic review and meta-analysis
P2860
Q26852507-86650349-3DE6-4421-B94D-A46053744CA8Q27692669-22E2D71B-951A-4217-8654-D33992F5D1BDQ28077579-0603D1C2-C5C3-4506-AE57-B05151E6EE03Q34623884-C1AB95B5-8919-4E21-82C6-83ECB0942663Q35671176-F51B52D8-60A2-4200-B5F6-36C89489AD63Q36197375-15E7FC62-182E-4FB8-9C05-B0724AEDF5FDQ36205492-28F5B652-4E64-4507-9A5E-A31380300C07Q36575287-79AA46FF-E671-433E-B244-F6CA3310EDE7Q36628618-F1AA7212-19F4-4753-93FE-FC84ACA51587Q37177513-D01948D4-CE7E-46D4-A581-D0B94B6EA221Q38486882-B91DC74B-6E76-414A-B161-3DEC06F8168CQ38584814-B645C7FE-66A2-40FB-8D1B-80AB60BDE9B8Q38790179-90E31703-82FB-43DA-B304-D41937B2CE38Q42340595-80F57873-D459-43E7-9544-6B07D00E0D5AQ46620066-0D489590-9F97-434D-9B14-DFBF37230FB6Q48132127-4E7950D5-0ED1-4588-A01C-C56985BFD986Q58754535-073BDC89-F3A3-4DB4-993B-6ED1C9FE19E0
P2860
Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@en
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@nl
type
label
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@en
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@nl
prefLabel
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@en
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@nl
P2093
P2860
P1433
P1476
Prognostic value of epidermal ...... resected lung adenocarcinomas.
@en
P2093
Lu-Jun Zhao
Qing-Song Pang
Wei-Shuai Liu
Zhi-Yong Yuan
P2860
P2888
P356
10.1007/S12032-013-0771-9
P577
2013-11-19T00:00:00Z